2018 대한부정맥학회 심실빈맥 전극도자 절제술 가이드라인 Part 2

참고문헌 (130)

1. Ling Z, "Radiofrequency ablation versus antiarrhythmic medication for treatment of ventricular premature beats from the right ventricular outflow tract : prospective randomized study", Circ Arrhythm Electrophysiol, 7, pp.237~243 (2014)
2. Zhong L, "Relative efficacy of catheter ablation vs antiarrhythmic drugs in treating premature ventricular contractions : a single-center retrospective study", Heart Rhythm, 11, pp.187~193 (2014)
3. Takemoto M, "Radiofrequency catheter ablation of premature ventricular complexes from right ventricular outflow tract improves left ventricular dilation and clinical status in patients without structural heart disease", J Am Coll Cardiol, 45, pp.1259~1265 (2005)
4. Morady F, "Long-term results of catheter ablation of idiopathic right ventricular tachycardia", Circulation, 82, pp.2093~2099 (1990)
5. Ventura R, "Decennial follow-up in patients with recurrent tachycardia originating from the right ventricular outflow tract : electrophysiologic characteristics and response to treatment", Eur Heart J, 28, pp.2338~2345 (2007)
6. Krittayaphong R, "Effect of atenolol on symptomatic ventricular arrhythmia without structural heart disease: a randomized placebo-controlled study", Am Heart J, 144, pp.e10~ (2002)
7. Gill JS, "Verapamil for the suppression of idiopathic ventricular tachycardia of left bundle branch block-like morphology", Am Heart J, 126, pp.1126~1133 (1993)
8. Hyman MC, "Class IC antiarrhythmic drugs for suspected premature ventricular contraction-induced cardiomyopathy", Heart Rhythm, 15, pp.159~163 (2018)
9. Tada H, "Prevalence and characteristics of idiopathic outflow tract tachycardia with QRS alteration following catheter ablation requiring additional radiofrequency ablation at a different point in the outflow tract", Pacing Clin Electrophysiol, 27, pp.1240~1249 (2004)
10. Yamada T, "The left ventricular ostium : an anatomic concept relevant to idiopathic ventricular arrhythmias", Circ Arrhythm Electrophysiol, 1, pp.396~404 (2008)
11. Liao Z, "Idiopathic Ventricular Arrhythmias Originating From the Pulmonary Sinus Cusp : Prevalence, Electrocardiographic", Electrophysiological Characteristics, and Catheter Ablation, 2015, pp.66, 2633~2644
12. Ouyang F, "Repetitive monomorphic ventricular tachycardia originating from the aortic sinus cusp : electrocardiographic characterization for guiding catheter ablation", J Am Coll Cardiol, 39, pp.500~508 (2002)
13. Yamada T, "Idiopathic ventricular arrhythmias originating from the aortic root prevalence, electrocardiographic and electrophysiologic characteristics, and results of radiofrequency catheter ablation", J Am Coll Cardiol, 52, pp.139~147 (2008)
14. Yamada T, "Idiopathic ventricular arrhythmias originating from the left ventricular summit : anatomic concepts relevant to ablation", Circ Arrhythm Electrophysiol, 3, pp.616~623 (2010)
15. Yamada T, "Idiopathic left ventricular arrhythmias originating adjacent to the left aortic sinus of valsalva : electrophysiological rationale for the surface electrocardiogram", J Cardiovasc Electrophysiol, 21, pp.170~176 (2010)
16. Lerman BB, "Adenosine-sensitive ventricular tachycardia : evidence suggesting cyclic AMP-mediated triggered activity", Circulation, 74, pp.270~280 (1986)
17. Dukes JW, "Ventricular Ectopy as a Predictor of Heart Failure and Death", J Am Coll Cardiol, 66, pp.101~109 (2015)
18. Sadron Blaye-Felice M, "Premature ventricular contraction-induced cardiomyopathy : Related clinical and electrophysiologic parameters", Heart Rhythm, 13, pp.103~110 (2016)
19. Ouyang F, "Ventricular arrhythmias arising from the left ventricular outflow tract below the aortic sinus cusps : mapping and catheter ablation via transseptal approach and electrocardiographic characteristics", Circ Arrhythm Electrophysiol, 7, pp.445~455 (2014)
20. Tada H, "Idiopathic ventricular arrhythmias arising from the pulmonary artery : prevalence, characteristics, and topography of the arrhythmia origin", Heart Rhythm, 5, pp.419~426 (2008)
21. Hai JJ, "Electrophysiologic characteristics of ventricular arrhythmias arising from the aortic mitral continuity-potential role of the conduction system", J Cardiovasc Electrophysiol, 26, pp.158~163 (2015)
22. Yamada T, "Efficacy of an Anatomical Approach in Radiofrequency Catheter Ablation of Idiopathic Ventricular Arrhythmias Originating From the Left Ventricular Outflow Tract", Circ Arrhythm Electrophysiol, 10, pp.e004959~ (2017)
23. Mountantonakis SE, "Ventricular arrhythmias from the coronary venous system : Prevalence, mapping, and ablation", Heart Rhythm, 12, pp.1145~1153 (2015)
24. Roberts-Thomson KC, "Coronary artery injury due to catheter ablation in adults : presentations and outcomes", Circulation, 120, pp.1465~1473 (2009)
25. Ouyang F, "Electroanatomic substrate of idiopathic left ventricular tachycardia : unidirectional block and macroreentry within the purkinje network", Circulation, 105, pp.462~469 (2002)
26. Nogami A, "Demonstration of diastolic and presystolic purkinje potentials as critical potentials in a macroreentry circuit of verapamil-sensitive idiopathic left ventricular tachycardia", J Am Coll Cardiol, 36, pp.811~823 (2000)
27. Belhassen B, "Response of recurrent sustained ventricular tachycardia to verapamil", Br Heart J, 46, pp.679~682 (1981)
28. Nogami A, "Idiopathic left ventricular tachycardia : assessment and treatment", Card Electrophysiol Rev, 6, pp.448~457 (2002)
29. Nogami A, "Verapamil-sensitive left anterior fascicular ventricular tachycardia : results of radiofrequency ablation in six patients", J Cardiovasc Electrophysiol, 9, pp.1269~1278 (1998)
30. Lin D, "Idiopathic fascicular left ventricular tachycardia : linear ablation lesion strategy for noninducible or nonsustained tachycardia", Heart Rhythm, 2, pp.934~939 (2005)
31. Bogun F, "Radiofrequency ablation of idiopathic left anterior fascicular tachycardia", J Cardiovasc Electrophysiol, 6, pp.1113~1116 (1995)
32. Snyder C, "Verapamil-sensitive ventricular tachycardia in an infant", Congenit Heart Dis, 1, pp.124~126 (2006)
33. Ohe T, "Idiopathic sustained left ventricular tachycardia : clinical and electrophysiologic characteristics", Circulation (1988)
34. Doppalapudi H, "Ventricular Tachycardia Originating From the Posterior Papillary Muscle in the Left VentricleCLINICAL PERSPECTIVE : A Distinct Clinical Syndrome", Circ Arrhythm Electrophysiol, 1, pp.23~29 (2008)
35. 반지은, "Electrophysiological Characteristics Related to Outcome after Catheter Ablation of Idiopathic Ventricular Arrhythmia Originating from the Papillary Muscle in the Left Ventricle", Korean Circulation Journal, 43(12), pp.811~818 (2013), 대한심장학회
36. Crawford T, "Ventricular arrhythmias originating from papillary muscles in the right ventricle", Heart Rhythm, 7, pp.725~730 (2010)
37. Yamada T, "Idiopathic Ventricular Arrhythmias Originating from the Papillary Muscles in the Left Ventricle : Prevalence, Electrocardiographic and Electrophysiological Characteristics, and Results of the Radiofrequency Catheter Ablation", J Cardiovasc Electrophysiol, 21, pp.62~69 (2010)
38. Yokokawa M, "Predictors of Successful Catheter Ablation of Ventricular Arrhythmias Arising from the Papillary Muscles", Heart Rhythm Off J Heart Rhythm Soc, 7, pp.1654~ (2010)
39. Priori SG, "2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death : The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology(ESC)Endorsed by : Association for European Paediatric and Congenital Cardiology(AEPC)", Eur Heart J, 36, pp.2793~2867 (2015)
40. Tada H, "Idiopathic ventricular arrhythmia arising from the mitral annulus", J Am Coll Cardiol, 45, pp.877~886 (2005)
41. Tada H, "Idiopathic ventricular arrhythmias originating from the tricuspid annulus : Prevalence, electrocardiographic characteristics, and results of radiofrequency catheter ablation", Heart Rhythm, 4, pp.7~16 (2007)
42. Priori SG, "2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death : The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology(ESC)Endorsed by : Association for European Paediatric and Congenital Cardiology(AEPC)", Eur Heart J, 36, pp.2793~2867 (2015)
43. Yeh S-J, "Adenosine-sensitive ventricular tachycardia from the anterobasal left ventricle", J Am Coll Cardiol, 30, pp.1339~1345 (1997)
44. Connolly SJ, "Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials", Eur Heart J, 21, pp.2071~2078 (2000)
45. Haïssaguerre M, "Role of Purkinje conducting system in triggering of idiopathic ventricular fibrillation", The Lancet, 359, pp.677~678 (2002)
46. Nogami A, "Mapping and ablation of idiopathic ventricular fibrillation from the Purkinje system", Heart Rhythm, 2, pp.646~649 (2005)
47. Haïssaguerre M, "Mapping and Ablation of Idiopathic Ventricular Fibrillation", Circulation, 106, pp.962~967 (2002)
48. Knecht S, "Long-Term Follow-Up of Idiopathic Ventricular Fibrillation Ablation : A Multicenter Study", J Am Coll Cardiol, 54, pp.522~528 (2009)
49. Meissner MD, "Ventricular fibrillation in patients without significant structural heart disease : A multicenter experience with implantable cardioverter-defibrillator therapy", J Am Coll Cardiol, 21, pp.1406~1412 (1993)
50. Schwartz PJ, "Diagnostic criteria for the long QT syndrome. An update", Circulation, 88, pp.782~784 (1993)
51. Schwartz PJ, "Impact of genetics on the clinical management of channelopathies", J Am Coll Cardiol, 62, pp.169~180 (2013)
52. Priori SG, "Risk stratification in the long-QT syndrome", N Engl J Med, 348, pp.1866~1874 (2003)
53. Ackerman MJ, "HRS", EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies, 2011, pp.13, 1077~1109
54. Schwartz PJ, "Genotype-phenotype correlation in the long-QT syndrome : gene-specific triggers for life-threatening arrhythmias", Circulation, 103, pp.89~95 (2001)
55. Moss AJ, "ECG T-wave patterns in genetically distinct forms of the hereditary long Q T syndrome", Circulation, 92, pp.2929~2934 (1995)
56. Ahn J, "Effectiveness of beta-blockers depending on the genotype of congenital long-QT syndrome: A meta-analysis", PloS one, 12, pp.e0185680~ (2017)
57. Priori SG, "Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers", JAMA, 292, pp.1341~1344 (2004)
58. Moss AJ, "Effectiveness nd limitations of beta-blocker therapy in congenital long-QT syndrome", Circulation, 101, pp.616~623 (2000)
59. Zareba W, "Implantable cardioverter defibrillator in high-risk long QT syndrome patients", J Cardiovasc Electrophysiol, 14, pp.337~341 (2003)
60. Schwartz PJ, "Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them? : data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator(LQTS ICD)Registry", Circulation, 122, pp.1272~1282 (2010)
61. Priori SG, "Risk stratification in the long-QT syndrome", N Engl J Med, 348, pp.1866~1874 (2003)
62. Jons C, "Risk of fatal arrhythmic events in long QT syndrome patients after syncope", J Am Coll Cardiol, 55, pp.783~788 (2010)
63. Schwartz PJ, "Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome", Circulation, 109, pp.1826~1833 (2004)
64. Schwartz PJ, "Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy", Circulation, 92, pp.3381~3386 (1995)
65. Moss AJ, "Safety and efficacy of flecainide in subjects with Long QT-3syndrome(DeltaKPQ mutation) : a randomized, double-blind, placebo-controlled clinical trial", Ann Noninvasive Electrocardiol, 10, pp.59~66 (2005)
66. Moss AJ, "Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome", J Cardiovasc Electrophysiol, 19, pp.1289~1293 (2008)
67. Bhandari AK, "Electrophysiologic testing in patients with the long QT syndrome", Circulation, 71, pp.63~71 (1985)
68. Priori SG, "2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC)", Eur Heart J, 36, pp.2793~2867 (2015)
69. Ahn J, "Right Ventricular Compression Mimicking Brugada-Like Electrocardiogram in a Patient with Recurrent Pectus Excavatum", Case reports in cardiology, 2017, pp.3047937~ (2017)
70. Nam GB, "Mode of onset of ventricular fibrillation in patients with early repolarization pattern vs. Brugada syndrome", Brugada syndrome, 31, pp.330~339 (2010)
71. Priori SG, "Natural history of Brugada syndrome : insights for risk stratification and management", Circulation, 105, pp.1342~1347 (2002)
72. Maury P, "Electrical storms in Brugada syndrome : review of pharmacologic and ablative therapeutic options", Indian Pacing Electrophysiol J, 5, pp.25~34 (2005)
73. Marquez MF, "Long-term efficacy of low doses of quinidine on malignant arrhythmias in Brugada syndrome with an implantable cardioverter-defibrillator : a case series and literature review", Heart Rhythm, 9, pp.1995~2000 (2012)
74. Haissaguerre M, "Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes", Circulation, 108, pp.925~928 (2003)
75. Nademanee K, "Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium", Circulation, 123, pp.1270~1279 (2011)
76. Kammeraad JA, "Predictors of sudden cardiac death after Mustard or Senning repair for transposition of the great arteries", J Am Coll Cardiol, 44, pp.1095~1102 (2004)
77. Khairy P, "Value of programmed ventricular stimulation after tetralogy of fallot repair : a multicenter study", Circulation, 109, pp.1994~2000 (2004)
78. Berul CI, "Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients", J Am Coll Cardiol, 51, pp.1685~1691 (2008)
79. Khairy P, "Implantable cardioverterdefibrillators in tetralogy of Fallot", Circulation, 117, pp.363~370 (2008)
80. Gatzoulis MA, "Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot : a multicentre study", Lancet, 356, pp.975~981 (2000)
81. Gonska BD, "Radiofrequency catheter ablation of right ventricular tachycardia late after repair of congenital heart defects", Circulation, 94, pp.1902~1908 (1996)
82. Ghai A, "Left ventricular dysfunction is a risk factor for sudden cardiac death in adults late after repair of tetralogy of Fallot", J Am Coll Cardiol, 40, pp.1675~1680 (2002)
83. Kadish A, "Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy", N Engl J Med, 350, pp.2151~2158 (2004)
84. Silka MJ, "Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30%undergo prophylactic implantation of an ICD? Patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% should undergo prophylactic implantation of an implantable cardioverter defibrillator", Circ Arrhythm Electrophysiol, 1, pp.298~306 (2008)
85. Calkins H, "Catheter ablation of ventricular tachycardia in patients with structural heart disease using cooled radiofrequency energy: results of a prospective multicenter study. Cooled RF Multi Center Investigators Group", J Am Coll Cardiol, 35, pp.1905~1914 (2000)
86. Khairy P, "PACES", HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease:developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD), 2014, pp.11, e102~e165
87. Zeppenfeld K, "Catheter ablation of ventricular tachycardia after repair of congenital heart disease : electroanatomic identification of the critical right ventricular isthmus", Circulation, 116, pp.2241~2252 (2007)
88. Gatzoulis KA, "Prognostic value of programmed ventricular stimulation for sudden death in selected high risk patients with structural heart disease and preserved systolic function", Int J Cardiol, 176, pp.1449~1451 (2014)
89. Downar E, "Ventricular tachycardia after surgical repair of tetralogy of Fallot : results of intraoperative mapping studies", J Am Coll Cardiol, 20, pp.648~655 (1992)
90. Nitta T, "Intraoperative electroanatomic mapping", Ann Thorac Surg, 93, pp.1285~1288 (2012)
91. Food and Drug Administration, "International Conference on Harmonisation; guidance on E14 Clinical Evaluation of QT", QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs; availability, 2005, pp.70, 61134~61135
92. Watanabe J, "Increased risk of antipsychotic-related QT prolongation during nighttime : a 24-hour Holter electrocardiogram recording study", J Clin Psychopharmacol, 32, pp.18~22 (2012)
93. Wu CS, "Antipsychotic drugs and the risk of ventricular arrhythmia and", or sudden cardiac death: a nation-wide case-crossover study, 2015, pp.4, e001568~
94. Sala M, "QT interval prolongation related to psychoactive drug treatment : a comparison of monotherapy versus polytherapy", Ann Gen Psychiatry, 4, pp.1~ (2005)
95. Fanoe S, "Risk of arrhythmia induced by psychotropic medications : a proposal for clinical management", Eur Heart J, 35, pp.1306~1315 (2014)
96. Girardin FR, "Drug-induced long QT in adult psychiatric inpatients : the 5-year cross-sectional ECG Screening Outcome in Psychiatry study", Am J Psychiatry, 170, pp.1468~1476 (2013)
97. van Rijsingen IA, "Risk factors for malignant ventricular arrhythmias in lamin a", c mutation carriers a European cohort study, 2012, pp.59, 493~500
98. Wahbi K, "Electrophysiological study with prophylactic pacing and survival in adults with myotonic dystrophy and conduction system disease", JAMA, 307, pp.1292~1301 (2012)
99. Laurent V, "Mortality in myotonic dystrophy patients in the area of prophylactic pacing devices", Int J Cardiol, 150, pp.54~58 (2011)
100. Meune C, "Primary prevention of sudden death in patients with lamin A", C gene mutations, 2006, pp.354, 209~210
101. Groh WJ, "Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1", N Engl J Med, 358, pp.2688~2697 (2008)
102. European Society of Gynecology(ESG), "ESC Guidelines on the management of cardiovascular diseases during pregnancy : The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology(ESC)", Eur Heart J, 32, pp.3147~3197 (2011)
103. Rashba EJ, "Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome. LQTS Investigators", Circulation, 97, pp.451~456 (1998)
104. Task Force on the Management of Cardiovascular Diseases During Pregnancy of the European Society of Cardiology, "Expert consensus document on management of cardiovascular diseases during pregnancy", Eur Heart J, 24, pp.761~781 (2003)
105. Dorian P, "Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation", N Engl J Med, 346, pp.884~890 (2002)
106. Joglar JA, "Treatment of cardiac arrhythmias during pregnancy : safety considerations", Drug Saf, 20, pp.85~94 (1999)
107. Cox JL, "Treatment of cardiac arrhythmias during pregnancy", Prog Cardiovasc Dis, 36, pp.137~178 (1993)
108. Young T, "The occurrence of sleep disordered breathing among middle-aged adults", N Engl J Med, 328, pp.1230~1235 (1993)
109. Simantirakis EN, "Severe bradyarrhythmias in patients with sleep apnoea : the effect of continuous positive airway pressure treatment : a longterm evaluation using an insertable loop recorder", Eur Heart J, 25, pp.1070~1076 (2004)
110. Gami AS, "Obstructive sleep apnea and the risk of sudden cardiac death : a longitudinal study of 10, 701 adults", J Am Coll Cardiol, 62, pp.610~616 (2013)
111. Antman EM, "Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study", Circulation, 81, pp.1744~1752 (1990)
112. Chan BS, "Digoxin-specific antibody fragments in the treatment of digoxin toxicity", Clin Toxicol, 52, pp.824~836 (2014)
113. Keren A, "Etiology, warning signs and therapy of torsade de pointes. A study of 10 patients", Circulation, 64, pp.1167~1174 (1981)
114. Tzivoni D, "Treatment of torsade de pointes with magnesium sulfate", Circulation, 77, pp.392~397 (1988)
115. Kannankeril P, "Drug-induced long QT syndrome", Pharmacol Rev, 62, pp.760~781 (2010)
116. Choy AM, "Normalization of acquired QT prolongation in humans by intravenous potassium", Circulation, 96, pp.2149~2154 (1997)
117. Yang T, "Extracellular potassium modulation of drug block of IKr. Implications for torsade de pointes and reverse usedependence", Circulation, 93, pp.407~411 (1996)
118. Hellestrand KJ, "Effect of the antiarrhythmic agent flecainide acetate on acute and chronic pacing thresholds", Pacing Clin Electrophysiol, 6, pp.892~899 (1983)
119. Echt DS, "Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs. Sodium channel block and action potential prolongation", Circulation, 79, pp.1106~1117 (1989)
120. Schwartz PJ, "Predicting the unpredictable : druginduced QT prolongation and torsades de pointes", J Am Coll Cardiol, 67, pp.1639~1650 (2016)
121. Tsai VW, "The efficacy of implantable cardioverter-defibrillators in heart transplant recipients : results from a multicenter registry", Circ Heart Fail, 2, pp.197~201 (2009)
122. McDowell DL, "Implantable defibrillators and cardiac resynchronization therapy in heart transplant recipients : results of a national survey", J Heart Lung Transplant, 28, pp.847~850 (2009)
123. Neylon A, "Implantable cardioverter-defibrillators in a heart transplant population : A single-center experience", J Heart Lung Transplant, 35, pp.682~684 (2016)
124. Corrado D, "Does sports activity enhance the risk of sudden death in adolescents and young adults", J Am Coll Cardiol, 42, pp.1959~1963 (2003)
125. Harmon KG, "Incidence of sudden cardiac death in athletes : a state-of-the-art review", Heart, 100, pp.1227~1234 (2014)
126. Borjesson M, "Cardiovascular evaluation of middleaged", senior individuals engaged in leisure-time sport activities : position stand from the sections of exercise physiology and sports cardiology of the European Association of Cardiovascular Prevention and Rehabilitation, 2011, pp.18, 446~458
127. Munger TM, "A population study of the natural history of Wolff–Parkinson–White syndrome in Olmsted County, Minnesota, 1953–1989", Circulation, 87, pp.866~873 (1993)
128. Cohen MI, "PACES", HRS expert consensus statement on the management of the asymptomatic young patient with a Wolff–Parkinson–White (WPW, ventricular preexcitation)electrocardiographic pattern: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology Foundation (ACCF), the American Heart Association (AHA), the American Academy of Pediatrics (AAP), and the Canadian Heart Rhythm Society (CHRS), 2012, pp.9, 1006~1024
129. Pappone C, "Wolff–Parkinson–White syndrome in the era of catheter ablation: insights from a registry study of 2169 patients", Circulation, 130, pp.811~819 (2014)
130. Kusumoto FM, "Systematic review for the 2017 AHA", ACC, American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society, pp.J Am Coll Cardiol

관련 논문AI추천